New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ENDP;S;BBY;AAPL;RIGL;CLWR;YELP;CVS;SAM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>
September 17, 2014
10:04 EDTAAPLDiscover rumored to be eyed as target by Apple, Bank Innovation says
Subscribe for More Information
09:36 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL WFM X YHOO TSLA TWTR RAX SHLD SPLS
09:11 EDTENDPEndo offer likely to be accepted by Auxilium, says Sterne Agee
Subscribe for More Information
09:10 EDTENDPOn The Fly: Pre-market Movers
Subscribe for More Information
08:44 EDTENDPBioDelivery Sciences remains takeout candidate for Endo, says Summer Street
Summer Street believes a potential takeover of BioDelivery Sciences (BDSI) by partner Endo (ENDP) is no less likely after Endo made a bid to acquire Auxilium (AUXL). The firm believes an Endo buyout of BioDelivery is likely a 2015 event when BioDelivery's Bunavail for opioid dependence is on the market and BEMA Buprenorphine is facing FDA approval. Summer Street says it is a buyer of BioDelivery Sciences on weakness this morning and keeps a Buy rating on the name with a $28 price target.
08:06 EDTENDPAuxilium likely to require higher bid from Endo, says MKM Partners
After Endo (ENDP) made a $28.10 per share bid for Auxilium (AUXL), MKM Partners believes that Endo will probably have to bid at least $32 to buy Auxilium. The firm raised its price target on Auxilium to $32 from $26 and reiterates a Buy rating.
07:58 EDTENDPEndo, Auxilium deal can create significant synergies, says Canaccord
Subscribe for More Information
07:43 EDTAAPLApple iPhone prices could rise, says RBC Capital
After conducting a survey of consumers, RBC Capital believes that average sales prices for Apple's iPhone could rise $90 quarter-over-quarter and $65 year-over-year, while gross margins could increase as a result of higher average memory per device. The firm raised its price target on the name to $114 from $110 and keeps an Outperform rating.
07:39 EDTENDPEndo deal for Auxilium highly complimentary, says UBS
Subscribe for More Information
07:22 EDTAAPLEarly reviews point to iPhone 6 battery life similar to iPhone 5s, BI says
After analyzing the first round of major tech publications' reviews of the iPhone 6 and 6 Plus, Business Insider said critics have "mixed" opinion's on the battery life of the 6 and that it "seems like" the smaller phone's battery life won't be radically different from the iPhone 5s. Reference Link
07:15 EDTENDPEndo bid for Auxilium positive, says Wells Fargo
Subscribe for More Information
07:14 EDTENDPAuxilium to 'carefully review' proposal from Endo for $28.10 per share
Subscribe for More Information
07:12 EDTENDPQLT Inc. provides update on merger with Auxilium
QLT Inc. (QLTI) announces that it has been advised by Auxilium Pharmaceuticals (AUXL) that Auxilium has received an unsolicited offer from Endo International (ENDP) to acquire all of the issued and outstanding shares of Auxilium. Auxilium has further advised QLT that the board of Auxilium is reviewing the Endo Proposal, and has not withdrawn, modified, withheld, changed or qualified its recommendation with respect to the proposed merger with QLT pursuant to the Agreement and Plan of Merger among QLT, Auxilium, QLT Holding, and QLT Acquisition, dated June 25. The Merger Agreement continues in full force and effect. In accordance with the Merger Agreement, QLT has consented to the adoption by Auxilium of a stockholder rights plan in response to the Endo Proposal.
07:11 EDTENDPAnalysts say Auxilium QLT deal could be snarled by Endo bid, Reuters says
Subscribe for More Information
07:04 EDTENDPAuxilium could be worth $34-$45/share in takeout, says Jefferies
Jefferies believes Auxilium (AUXL) could be worth more than the $28.10 per share offer by Endo (ENDP). The firm says it can get to valuations of $34-$45 per share for Auxilium under a takeout scenario. Jefferies thinks proposed acquisition cost "leaves considerable value on the table." It keeps a Buy rating on Auxilium with a $34 price target. In pre-open trading, Auxilium is trading well above Endo's offer price at $30.26 per share, up 41% or $8.74.
06:36 EDTENDPEndo volatility expected to move on Endo acquisition proposal
Subscribe for More Information
06:31 EDTAAPLLG Display to supply AMOLED panels for Apple Watch, DigiTimes reports
LG Display (LPL) are expected to supply Apple (AAPL) 5M AMOLED panels a month in 2015 for the Apple Watch, reports DigiTimes. According to sources from LG Display, Apple aims to sell upwards of 50M Apple Watches in 2015. Apple will reportedly not purchase AMOLED panels from Samsung (SSNLF) Display and instead will have LG as the sole panel provider for the Apple Watch. Reference Link
06:29 EDTAAPLApple iPhone 6 products sell out fast in Taiwan market, DigiTimes says
Subscribe for More Information
06:25 EDTENDPAuxilium volatility expected to move on Endo acquisition proposal
Subscribe for More Information
06:17 EDTAAPLApple supplier reportedly struggling to meet iPhone demand, WSJ reports
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use